longevity ethics
10% Drop in CRISPR Costs Through Longevity Science Ethics
A 10 percent drop in CRISPR costs is achievable when longevity science ethics guide policy decisions. In 2023 the Cedars-Sinai panel reported a 35 percent reduction in ethical ambiguities, showing how data-driven ethics can reshape biotech economics. Medical Disclaimer: This article is for informational purposes only and does not constitute